AnalysisNews

BDPT today

Trend

—

Key levels

—

Latest news & SEC filings

SEC FilingBioadaptives, Inc. filed a report on a major company event (Form 8-K)

All BDPT news →

OTC · Healthcare

BIOADAPTIVES, INC. (BDPT)

$0.00+0.00 (+0.00%)
WATCHLISTGrade: C+Risk: HIGH

What Is the Price Target for BDPT?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.00Upside: +0.0%Confidence: 20%Method: No Coverage

Is BDPT a Buy or Sell Right Now?

51
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 44.3% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BDPT.

Start Free Trial →

Is BDPT Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

24

Moat Score

NONE

4/9

Piotroski Score

-155.5

Altman Z-Score

What Is Smart Money Doing with BDPT?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

BDPT Growth Story

Revenue YoY

44.3%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-36.36%

FCF Growth YoY

-114.0%

Revenue Trend

ACCELERATING

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for BIOADAPTIVES, INC. (BDPT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

BDPT — frequently asked questions

Why is BDPT stock moving today?

Latest BDPT news — Nov 4, 2026: Bioadaptives, Inc. filed a report on a major company event (Form 8-K)

Did BDPT beat earnings?

BDPT last reported on Aug 19, 2026: EPS $0.01.

Does BDPT pay a dividend?

BDPT does not currently pay a dividend.

What are insiders doing with BDPT?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on BDPT?

Nov 4, 2026: Bioadaptives, Inc. filed a report on a major company event (Form 8-K)